Morphology: A Keystone in Therapeutic Decision Making of Post Therapy Tumour Regression in Ovarian Tumours
Introduction: Ovarian carcinoma is one of the most common malignancies of the female genital tract. Treating ovarian cancer with Neoadjuvant Chemotherapy (NACT) followed by Interval Debulking Surgery (IDS) is said to reduce surgical morbidity and has equivalent survival times when compared with prim...
Main Authors: | K CHANDRAMOULEESWARI, K ASHWINI |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2018-11-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/12264/35182_CE[Ra1]_F(SL)_PF1(AGAK)_PFA(AK)_PB(AGRK)_PN(P).pdf |
Similar Items
-
Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals
by: Kobal Borut, et al.
Published: (2018-09-01) -
Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
by: Kazuto Nakamura, et al.
Published: (2020-08-01) -
Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort
by: Zheng Feng, et al.
Published: (2021-02-01) -
Does preoperative CA-125 cutoff value and percent reduction in CA-125 levels correlate with surgical and survival outcome after neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer? – Our experience from a tertiary cancer institute
by: Monisha Gupta, et al.
Published: (2020-01-01) -
The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)